BRIEF published on 12/15/2025 at 22:10, 3 months 6 days ago Abivax : Résultats financiers du troisième trimestre 2025 Résultats Financiers Abivax Trésorerie Perte Nette Dépenses R&D
BRIEF published on 12/15/2025 at 22:10, 3 months 6 days ago Abivax: Third Quarter 2025 Financial Results Financial Results Treasury Abivax Net Loss R&D Expenditures
BRIEF published on 12/15/2025 at 22:10, 3 months 6 days ago Abivax publie ses résultats financiers du troisième trimestre 2025 Dépenses De R&D Financement Des Biotechnologies Abivax Financials Résultats Du Troisième Trimestre 2025 Position De Trésorerie
BRIEF published on 12/15/2025 at 22:10, 3 months 6 days ago Abivax Reports Third Quarter 2025 Financial Results Cash Position Biotech Funding R&D Expenses Q3 2025 Results Abivax Financials
PRESS RELEASE published on 12/15/2025 at 22:05, 3 months 6 days ago Abivax présente ses résultats financiers du troisième trimestre 2025 Abivax présente ses résultats financiers du troisième trimestre 2025 avec trésorerie de 589,7 millions d'euros et une autonomie financière jusqu'au quatrième trimestre 2027 Résultats Financiers Abivax Troisième Trimestre Autonomie Financière 589,7 Millions D'euros
PRESS RELEASE published on 12/15/2025 at 22:05, 3 months 6 days ago Abivax Presents Third Quarter 2025 Financial Results Abivax presents its third quarter 2025 financial results with EUR 589.7 cash and cash equivalents, providing key updates on its business and operational goals Financial Results Abivax Third Quarter Operational Goals Cash Equivalents
BRIEF published on 12/12/2025 at 18:05, 3 months 9 days ago ABIVAX: Publication of Capital and Voting Rights Data as of November 30, 2025 Financial Information Share Capital Voting Rights Abivax AMF Regulations
BRIEF published on 12/12/2025 at 18:05, 3 months 9 days ago ABIVAX : Publication des Données Capital et Droits de Vote au 30 Novembre 2025 Droits De Vote Capital Social Abivax Réglementation AMF Informations Financières
PRESS RELEASE published on 12/12/2025 at 18:00, 3 months 9 days ago ABIVAX: Nombre d’actions composant le capital social et nombre total de droits de vote au 30.11.25. ABIVAX révèle le nombre d'actions et de droits de vote au 30.11.25 conformément à la réglementation financière. Détails disponibles dans le communiqué officiel Droits De Vote Actions Abivax Réglementation Communiqué
BRIEF published on 11/19/2025 at 18:05, 4 months 2 days ago ABIVAX : Informations sur le capital social et les droits de vote au 31 octobre 2025 Euronext Paris Droits De Vote Capital Social AMF Abivax
Published on 03/20/2026 at 13:30, 1 day 12 hours ago Unusual Machines Announces Pricing of Approximately $150 Million Public Offering of Common Stock
Published on 03/20/2026 at 12:30, 1 day 13 hours ago CANEX Metals Announces the Numbers of Gold Basin Shares Taken up by Canex Metals
Published on 03/20/2026 at 22:45, 1 day 2 hours ago Investor Alert: Berger Montague (Canada) PC represents investors that purchased shares of Super Micro Computer, Inc. listed on the CBOE Canada and elsewhere
Published on 03/20/2026 at 21:05, 1 day 4 hours ago Fractal EMS Receives ISO/IEC 9001 and 27001 Certifications
Published on 03/20/2026 at 21:05, 1 day 4 hours ago Nebius Group announces closing of private offering of convertible senior notes, with aggregate gross proceeds of approximately $4.3 billion
Published on 03/20/2026 at 21:00, 1 day 4 hours ago BRP Unveils the Winners of its 6th International Design Challenge
Published on 03/20/2026 at 20:05, 1 day 5 hours ago INVESTOR ALERT: Goeasy Ltd. Shareholder Class Action
Published on 03/20/2026 at 19:00, 1 day 6 hours ago AXA - Conditions for availability or consultation of information relating to AXA’s Shareholders’ Meeting of April 30, 2026
Published on 03/20/2026 at 19:00, 1 day 6 hours ago AXA - Modalités de mise à disposition ou de consultation des informations relatives à l’Assemblée Générale du 30 avril 2026
Published on 03/20/2026 at 18:15, 1 day 7 hours ago Publication of AXA’s 2025 Universal Registration Document
Published on 03/20/2026 at 18:15, 1 day 7 hours ago Mise à disposition du Document d’Enregistrement Universel 2025 d’AXA
